about
Non-cross-bridged tetraazamacrocyclic chelator for stable (64)cu-based radiopharmaceuticalsVivid tumor imaging utilizing liposome-carried bimodal radiotracerA New Synthesis of TE2A-a Potential Bifunctional Chelator for (64)Cu.Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89Molecular targeted α-particle therapy for oncologic applications.Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.Phosphonate Pendant Armed Propylene Cross-Bridged Cyclam: Synthesis and Evaluation as a Chelator for Cu-64.Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization.Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development.Enhancing tissue permeability with MRI guided preclinical focused ultrasound system in rabbit muscle: From normal tissue to VX2 tumor.Longitudinal monitoring adipose-derived stem cell survival by PET imaging hexadecyl-4-¹²⁴I-iodobenzoate in rat myocardial infarction model.Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.Propylene cross-bridged macrocyclic bifunctional chelator: a new design for facile bioconjugation and robust (64)Cu complex stability.Revival of TE2A; a better chelate for Cu(II) ions than TETA?A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant Zr-immuno-PET agentsNew macrobicyclic chelator for the development of ultrastable 64Cu-radiolabeled bioconjugate
P50
Q33636030-CD3CD38F-D3C2-451C-AA55-6DADB0019C2BQ33636265-2B524605-7CBA-4F25-B9ED-1AA0A7414688Q33704117-AF3C891A-0553-41E5-A51F-5A9E053B63EFQ33757834-17195E53-AB3A-482C-92DB-8E93B6CC6B55Q35814989-5BB81CC7-5B18-4C42-8E1F-0D16524E69DDQ35865849-05D64141-223B-4CF8-A2E7-BE70F0FDCF75Q36281030-A4D9261D-1839-49EC-8808-BDF9E428380DQ36644332-DBA04889-E91D-4A9D-94F2-6501D82CBD3AQ36723768-2F4DF49D-72C3-430A-8722-09529FAB2735Q37718007-55F1E746-B086-4B2F-ABC7-EF1CDE214926Q47832885-1FFA994B-3C66-4515-A99C-9048B882062CQ48695495-382EB4FC-377C-4384-BE15-36B67872E1E1Q51803844-14745CF8-2746-45E6-8299-127BF63A7421Q53055752-FDC62541-AF95-4DA3-B6B0-AB5B0E81764BQ53466758-C501C5CC-7511-4CC3-B729-D0AE05A42CB8Q56976536-544B111A-76E6-43D4-BD9F-40B51DB51F1DQ83433254-83908E27-CDA5-4AAE-BBB9-F0B62B407F73
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Darpan Pandya
@ast
Darpan Pandya
@en
Darpan Pandya
@es
Darpan Pandya
@nl
Darpan Pandya
@sl
type
label
Darpan Pandya
@ast
Darpan Pandya
@en
Darpan Pandya
@es
Darpan Pandya
@nl
Darpan Pandya
@sl
prefLabel
Darpan Pandya
@ast
Darpan Pandya
@en
Darpan Pandya
@es
Darpan Pandya
@nl
Darpan Pandya
@sl
P1053
S-3967-2016
P106
P1153
36053755200
P31
P3829
P496
0000-0001-6288-5172